Alcohol and Drug Dependence Treatment: Pharmacogenetics
暂无分享,去创建一个
[1] Ming D. Li,et al. Determination of genotype combinations that can predict the outcome of the treatment of alcohol dependence using the 5-HT(3) antagonist ondansetron. , 2013, The American journal of psychiatry.
[2] P. Randall,et al. Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes. , 2012, Alcoholism, clinical and experimental research.
[3] C. Benkelfat,et al. Influence of the OPRM1 A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone. , 2012, Pharmacogenomics.
[4] R. González-Sarmiento,et al. Association of µ‐opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta‐analysis , 2012, Addiction biology.
[5] D. Oslin,et al. The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. , 2012, Alcoholism, clinical and experimental research.
[6] P. Miller,et al. Medical Treatment of Alcohol Dependence: A Systematic Review , 2011, International journal of psychiatry in medicine.
[7] Ming D. Li,et al. Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking. , 2011, The American journal of psychiatry.
[8] D. Couper,et al. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. , 2008, Archives of general psychiatry.
[9] R. Rosenheck,et al. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. , 2007, Alcoholism, clinical and experimental research.
[10] D. Oslin,et al. A Functional Polymorphism of the μ-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients , 2003, Neuropsychopharmacology.